Psychedelics in the treatment of cluster headaches
Michal Židó, Tomáš Páleníček, Ivana Štětkářová
Klinická farmakologie a farmacie April 29, 2025 DOI: 10.36290/far.2025.021 via OpenAlex
Summary
AI-generated from the abstractPsychedelics are psychoactive substances that typically induce changes in perception, thinking, emotionality, and cognitive processes immediately after use. Their antidepressant and anxiolytic effects are being intensively studied. A main advantage is rapid onset of action with long-lasting effects after one or only a few doses, along with a good safety profile. These substances may also have potential in treating chronic pain from neuropathy and primary headaches, such as cluster headache. Cluster headache is a rare disorder with episodes of intense pain and autonomic symptoms that can severely limit patients. Although conventional treatment is sufficiently effective and safe for most patients, a subgroup does not respond well. Based on recent data, tryptamine and ergoline psychedelics like psilocybin and LSD and some derivatives represent a new potential therapeutic source, though still experimental.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Headaches Cluster headache Cluster spacecraft Psychology Psychiatry |
| Key finding | Psychedelics such as psilocybin and LSD may offer a new experimental treatment option for cluster headache patients who do not respond to conventional therapy. |
Abstract
Psychedelika jsou psychoaktivn ltky, kter bezprostedn po uit typicky vyvolvaj zmny vnmn, mylen, emotivity a kognitivnch proces. V posledn dob se intenzivn zkoum jejich antidepresivn a anxiolytick efekt. Hlavn vhodou tchto ltek je rychl nstup inku s dlouhodobm inkem po podn jedn i jen nkolika mlo dvek. Maj tak dobr bezpenostn profil. Dal vyuit mohou mt tyto ltky v lb chronickch bolest u neuropatie a primrnch bolest hlavy, napklad cluster headache. Cluster headache neboli syndrom nakupench bolest hlavy je vzcn onemocnn projevujc se epizodami intenzivnch bolest hlavy s vegetativnm doprovodem, kter mohou pacienty vrazn limitovat. I kdy je konvenn lba u vtiny pacient dostaten inn a bezpen, existuje urit skupina pacient, u kterch tomu tak nen. Proto se nadle ptr po novch lebnch monostech. Nov potenciln zdroj terapie cluster headache me na zklad recentnch dat pedstavovat prv i skupina tryptaminovch a ergolinovch psychedelik, napklad psilocybin a diethylamid kyseliny lysergov (LSD) a nkter jejich derivty. Jedn se vak zatm pouze o lbu experimentln.